Finally, about the other points you raised, we recommend you (and everyone interested in the theme) check the new version of the report published by Ambitious Impact/Charity Entrepreneurship when recommending this intervention for CE’s next incubation round[1].
AIM/CE researchers dedicated a few hours to polishing the remaining loose ends in our previous version. It includes a model for calculating the mortality reductions based on diarrhea case-fatality rates. This is a slightly enhanced version of our model and represents an interesting proposition on how to extrapolate the effect of the intervention from cases to mortality—given more time, it could even be expanded to consider pathogen-specific case-fatality rates, which should be even better.
Finally, about the other points you raised, we recommend you (and everyone interested in the theme) check the new version of the report published by Ambitious Impact/Charity Entrepreneurship when recommending this intervention for CE’s next incubation round [1].
AIM/CE researchers dedicated a few hours to polishing the remaining loose ends in our previous version. It includes a model for calculating the mortality reductions based on diarrhea case-fatality rates. This is a slightly enhanced version of our model and represents an interesting proposition on how to extrapolate the effect of the intervention from cases to mortality—given more time, it could even be expanded to consider pathogen-specific case-fatality rates, which should be even better.
We, the authors of the originial report, had only very limited participation in the changes made between the two versions.